Wilson Therapeutics appoints Rick Lilley as Chief Regulatory Officer
Wilson Therapeutics AB (publ), announces the appointment of Rick Lilley as Chief Regulatory Officer. Dr Lilley will report to CEO Jonas Hansson and will join the company’s management team.Dr Lilley is a senior global regulatory executive with more than 30 years of experience in the pharmaceutical and biotech industries with a strong track record of achievements and leadership in regulatory affairs and drug development in Europe, Japan and USA. He has successfully led the regulatory process through registration and approval for more than 20 products, including orphan drugs, in diverse